[LGND] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- 745.92%
YoY- 791.49%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 59,590 45,663 90,043 56,157 50,464 33,375 27,995 65.24%
PBT -56,789 79,226 95,579 55,312 30,665 12,071 8,300 -
Tax -14,307 11,864 22,419 10,033 37,675 3,645 2,242 -
NP -42,482 67,362 73,160 45,279 -7,010 8,426 6,058 -
Tax Rate - -14.97% -23.46% -18.14% -122.86% -30.20% -27.01% -
Total Cost 102,072 -21,699 16,883 10,878 57,474 24,949 21,937 177.93%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin -71.29 147.52 81.25 80.63 -13.89 25.25 21.64 -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -2.02 3.19 3.45 2.13 -0.34 0.40 0.29 -
EPS Diluted -2.02 2.80 2.99 1.83 -0.33 0.36 0.26 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.